IRON Disc Medicine, Inc. - Common Stock
$80,38
Kurs · Aug 18, 2026
Fundamentaldaten per Jul 30, 2026
52W-Spanne
$56–$100
57% of range
Analystenbewertung
BUY
19 analysts
Kursziel
$101
+26% upside
P/E (TTM)
-13.4
ROE
-31.3%
Nettogewinnmarge
—
IRON Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$80.38
Marktkapitalisierung
$3.05B
P/E (TTM)
-13.4
EPS (TTM)
$-6.01
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-31.3%
Verschuldungsgrad
—
52W-Spanne
$56 – $100
IRON Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-6.01
2021-12-31
→
2025-12-31
Freier Cashflow
$-181M
2021-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
IRON
Peer-Median
P/E (TTM)
-13.4
—
P/B (K/B)
4.1
3.3
Price / FCF (Kurs / FCF)
-16.8
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
IRON
Peer-Median
ROA
-32.6%
-36.2%
ROE
-31.3%
-43.7%
ROIC
-32.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
IRON
Peer-Median
Current Ratio (Liquiditätsgrad)
21.9
9.7
Quick Ratio
21.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
IRON
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
IRON
Peer-Median
IRON Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
19 Analysten
- Starker Kauf 7 36,8%
- Kauf 11 57,9%
- Halten 1 5,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-15
Median
$100.00
Jetzt
$80.38
Tief
$79.00
Hoch
$128.00
Median-Ziel
$100.00
+24,4%
Mittelwert-Ziel
$101.17
+25,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.54 | $-1.78 | 0.24% |
| 31. März 2026 | $-1.65 | $-1.75 | 0.10% |
| 31. Dezember 2025 | $-1.64 | $-1.78 | 0.14% |
| 30. September 2025 | $-1.77 | $-1.49 | -0.28% |
| 30. Juni 2025 | $-1.58 | $-1.18 | -0.40% |
| 31. März 2025 | $-1.02 | $-1.16 | 0.14% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
| SLS | $577M | -15.1 | — | — | -55.4% | — |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $171M | $97M | $69M | $33M | $25M | $28M | |
| SG&A Expense | $65M | $33M | $22M | $14M | $6M | $6M | |
| Operating Expenses | $236M | $130M | $91M | $47M | $31M | $34M | |
| Operating Income | $-236M | $-130M | $-91M | $-47M | $-31M | $-34M | |
| Interest Expense | · | · | · | · | $2M | $7M | |
| Other Non-op | $45.0K | $-2.0K | $-2.0K | $0 | $-5M | · | |
| Pretax Income | $-212M | $-109M | $-76M | $-47M | · | · | |
| Income Tax | $361.0K | $355.0K | $99.0K | $0 | · | · | |
| Net Income | $-212M | $-109M | $-76M | $-47M | $-36M | $-41M | |
| EPS (Basic) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · | |
| EPS (Diluted) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 | · | |
| Shares (Basic) | 35,295,663 | 27,606,022 | 22,315,877 | 1,039,490 | 878,407 | · | |
| Shares (Diluted) | 35,295,663 | 27,606,022 | 22,315,877 | 1,039,490 | 878,407 | · | |
| EBITDA | $-236M | $-130M | $-91M | $-47M | $-69M | · |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91M | $192M | $360M | $195M | $88M | $5M | |
| Short-term Investments | $700M | $297M | $0 | · | · | · | |
| Prepaid Expense | $13M | $4M | $5M | $4M | $2M | $562.0K | |
| Current Assets | $804M | $494M | $366M | $198M | $90M | $5M | |
| PP&E (Net) | $1M | $751.0K | $170.0K | $168.0K | $106.0K | $294.0K | |
| PP&E (Gross) | · | · | · | · | $0 | $955.0K | |
| Accum. Depreciation | · | $401.0K | $245.0K | $145.0K | $56.0K | $661.0K | |
| Other Non-current Assets | $726.0K | $838.0K | $234.0K | $116.0K | $180.0K | · | |
| Total Assets | $807M | $497M | $368M | $200M | $92M | $8M | |
| Accounts Payable | $9M | $8M | $13M | $16M | $3M | $2M | |
| Accrued Liabilities | $16M | $8M | $6M | $6M | $4M | $492.6K | |
| Current Liabilities | $37M | $23M | $21M | $23M | $13M | $25M | |
| Capital Leases | $1M | $2M | $1M | $1M | $1M | · | |
| Total Liabilities | $67M | $53M | $23M | $24M | $15M | $30M | |
| Long-term Debt | $29M | $28M | $0 | · | · | $14M | |
| Common Stock | $4.0K | $3.0K | $2.0K | $2.0K | $0 | $2.0K | |
| Paid-in Capital | $1.25B | $741M | $534M | $289M | $1M | $91M | |
| Retained Earnings | $-510M | $-298M | $-189M | $-112M | $-65M | $-113M | |
| AOCI | $965.0K | $289.0K | $0 | · | · | · | |
| Stockholders' Equity | $740M | $444M | $345M | $177M | $-64M | $-29M | |
| Liabilities + Equity | $807M | $497M | $368M | $200M | $92M | $8M | |
| Shares Outstanding | 37,890,616 | 29,865,030 | 24,360,233 | 17,403,315 | 909,418 | 15,565,380 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $281.0K | $156.0K | $100.0K | $89.0K | $32.0K | · | |
| Stock-based Comp | $34M | $17M | $6M | $2M | $507.0K | $983.0K | |
| Deferred Tax | $0 | · | · | · | · | · | |
| Other Non-cash | $-3M | $-2M | $-3M | $2M | · | · | |
| Operating Cash Flow | $-180M | $-94M | $-73M | $-42M | $-28M | $-33M | |
| CapEx | $933.0K | $505.0K | $89.0K | $151.0K | $68.0K | $22.0K | |
| Investing Cash Flow | $-394M | $-292M | $-89.0K | $-151.0K | $-68.0K | $-22.0K | |
| Debt Issued | $0 | $29M | $0 | · | · | · | |
| Net Debt Issued | $0 | $29M | · | · | · | · | |
| Stock Issued | · | · | $0 | $54M | $0 | $20M | |
| Net Stock Activity | · | · | $0 | $54M | $0 | · | |
| Financing Cash Flow | $473M | $218M | $239M | $149M | $90M | $34M | |
| Net Change in Cash | $-101M | $-168M | $166M | $107M | $62M | $2M | |
| Taxes Paid | $349.0K | $300.0K | $100.0K | $0 | $0 | · | |
| Free Cash Flow | $-181M | $-94M | $-74M | $-42M | $-60M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -32.6% | -25.3% | -26.9% | -32.0% | -96.6% | · | |
| ROE | -31.3% | -24.0% | -21.7% | -120.0% | -54.1% | · | |
| ROIC | -32.0% | -29.3% | -26.4% | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.9 | 21.2 | 17.1 | 8.8 | 9.4 | 2.2 | |
| Quick Ratio | 21.6 | 21.0 | 16.8 | 8.6 | 9.2 | 2.0 | |
| Interest Coverage | · | · | · | · | -32.0 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-212M | $-109M | $-76M | $-47M | $-36M | $-41M | |
| Market Cap | $3.01B | $1.89B | $1.41B | $346M | $3.77B | · | |
| P/E | -13.2 | -16.0 | -16.9 | -0.4 | -2.1 | · | |
| P/B | 4.1 | 4.3 | 4.1 | 2.0 | 30.2 | · | |
| P / Tangible Book | 4.1 | 4.3 | 4.1 | 2.0 | · | · | |
| P / Cash Flow | -16.7 | -20.2 | -19.2 | -8.2 | -63.2 | · | |
| P / FCF | -16.6 | -20.1 | -19.1 | -8.2 | -63.1 | · | |
| Earnings Yield | -7.6% | -6.2% | -5.9% | -226.5% | -46.9% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $46M | $46M | $50M | $46M | $28M | $25M | $25M | $23M | $24M | $23M | $14M | $12M | $20M | $10M | $8M | |
| SG&A Expense | $18M | $24M | $21M | $17M | $15M | $12M | $10M | $8M | $7M | $8M | $7M | $5M | $5M | $5M | $5M | $3M | |
| Operating Expenses | $65M | $70M | $67M | $68M | $61M | $40M | $35M | $33M | $31M | $31M | $30M | $19M | $17M | $25M | $15M | $10M | |
| Operating Income | $-65M | $-70M | $-67M | $-68M | $-61M | $-40M | $-35M | $-33M | $-31M | $-31M | $-30M | $-19M | $-17M | $-25M | $-15M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41.0K | |
| Other Non-op | $-12.0K | $22.0K | $-2.0K | $-18.0K | $68.0K | $-3.0K | $3.0K | $9.0K | $-13.0K | $-1.0K | $-10.0K | $13.0K | $-5.0K | $0 | $-107.0K | $0 | |
| Pretax Income | $-59M | $-63M | $-60M | $-62M | $-55M | $-34M | $-29M | $-26M | $-26M | $-27M | $-24M | $-14M | $-16M | $-23M | $-11M | $-16M | |
| Income Tax | $69.0K | $51.0K | $88.0K | $102.0K | $52.0K | $119.0K | $176.0K | $114.0K | $60.0K | $5.0K | $32.0K | $20.0K | $24.0K | $23.0K | $0 | $0 | |
| Net Income | $-60M | $-64M | $-61M | $-62M | $-55M | $-34M | $-29M | $-27M | $-26M | $-27M | $-24M | $-14M | $-16M | $-23M | $-11M | $-16M | |
| EPS (Basic) | $-1.54 | $-1.65 | $-1.64 | $-1.77 | $-1.58 | $-1.02 | $-0.95 | $-0.89 | $-1.03 | $-1.09 | $-0.90 | $-0.58 | $-0.74 | $-1.20 | $-7.42 | $-16.82 | |
| EPS (Diluted) | $-1.54 | $-1.65 | $-1.64 | $-1.77 | $-1.58 | $-1.02 | $-0.95 | $-0.89 | $-1.03 | $-1.09 | $-0.90 | $-0.58 | $-0.74 | $-1.20 | $-7.42 | $-16.82 | |
| Shares (Basic) | 38,685,565 | 38,491,433 | -68,232,365 | 35,178,691 | 35,024,592 | 33,324,745 | -52,788,441 | 29,935,551 | 25,649,043 | 24,809,869 | -42,440,809 | 24,316,817 | 21,484,955 | 18,954,914 | -1,789,283 | 960,317 | |
| Shares (Diluted) | 38,685,565 | 38,491,433 | -68,232,365 | 35,178,691 | 35,024,592 | 33,324,745 | -52,788,441 | 29,935,551 | 25,649,043 | 24,809,869 | -42,440,809 | 24,316,817 | 21,484,955 | 18,954,914 | -1,789,283 | 960,317 | |
| EBITDA | $-65M | $-69M | · | $-68M | $-61M | $-40M | · | $-33M | $-31M | $-31M | · | $-19M | $-17M | $-25M | · | $-4M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $99M | $89M | $91M | $141M | $127M | $123M | $192M | $193M | $281M | $343M | · | $371M | $378M | $236M | $195M | $102M | |
| Short-term Investments | $619M | $641M | $700M | $475M | $523M | $572M | $297M | $295M | $220M | · | · | · | · | · | · | · | |
| Prepaid Expense | $15M | $17M | $13M | $11M | $12M | $11M | $4M | $6M | $7M | $9M | · | $4M | $4M | $6M | $4M | $3M | |
| Current Assets | $733M | $747M | $804M | $627M | $662M | $706M | $494M | $493M | $508M | $352M | · | $374M | $382M | $242M | $198M | $105M | |
| PP&E (Net) | $980.0K | $1M | $1M | $1M | $1M | $1M | $751.0K | $79.0K | $98.0K | $211.0K | · | $183.0K | $159.0K | $180.0K | $168.0K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | $392.0K | $381.0K | $271.0K | · | $220.0K | $195.0K | $170.0K | $145.0K | · | |
| Other Non-current Assets | $496.0K | $721.0K | $726.0K | $840.0K | $840.0K | $839.0K | $838.0K | $236.0K | $236.0K | $235.0K | · | $116.0K | $116.0K | $116.0K | $116.0K | $1M | |
| Total Assets | $735M | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M | $354M | · | $376M | $384M | $244M | $200M | $106M | |
| Accounts Payable | $7M | $12M | $9M | $7M | $6M | $7M | $8M | $4M | $5M | $5M | · | $8M | $5M | $6M | $16M | $1M | |
| Accrued Liabilities | $9M | $7M | $16M | $11M | $6M | $4M | $8M | $6M | $4M | $9M | · | $6M | $4M | $4M | $6M | · | |
| Current Liabilities | $30M | $31M | $37M | $27M | $21M | $19M | $23M | $25M | $20M | $15M | · | $14M | $10M | $10M | $23M | $1M | |
| Capital Leases | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | · | $2M | $2M | $945.0K | $1M | · | |
| Total Liabilities | $91M | $62M | $67M | $57M | $51M | $49M | $53M | $27M | $21M | $16M | · | $18M | $13M | $11M | $24M | $1M | |
| Long-term Debt | $59M | $29M | $29M | $29M | $29M | $29M | $28M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | |
| Paid-in Capital | $1.28B | $1.26B | $1.25B | $1.02B | $1.00B | $992M | $741M | $736M | $731M | $554M | · | $524M | $522M | $368M | $289M | $315M | |
| Retained Earnings | $-633M | $-574M | $-510M | $-450M | $-387M | $-332M | $-298M | $-269M | $-242M | $-216M | · | $-165M | $-151M | $-135M | $-112M | $-210M | |
| AOCI | $-2M | $-571.0K | $965.0K | $718.0K | $273.0K | $535.0K | $289.0K | $741.0K | $-60.0K | · | · | · | · | · | · | · | |
| Stockholders' Equity | $644M | $688M | $740M | $573M | $614M | $660M | $444M | $468M | $489M | $338M | $345M | $359M | $371M | $233M | $177M | $105M | |
| Liabilities + Equity | $735M | $750M | $807M | $630M | $665M | $709M | $497M | $495M | $510M | $354M | · | $376M | $384M | $244M | $200M | $106M | |
| Shares Outstanding | 38,345,666 | 38,190,464 | 37,890,616 | 35,006,636 | 34,694,882 | 34,581,222 | 29,865,030 | 29,748,154 | 29,707,997 | 24,695,885 | · | 24,139,078 | 22,850,894 | 19,575,242 | 17,403,315 | 43,299,453 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90.0K | $89.0K | $89.0K | $87.0K | $85.0K | $20.0K | $9.0K | $11.0K | $110.0K | $26.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $24.0K | |
| Stock-based Comp | $14M | $12M | $10M | $10M | $8M | $6M | $4M | $4M | $4M | $4M | $2M | $1M | $1M | $1M | $993.0K | $-3M | |
| Other Non-cash | · | $-11M | · | · | · | $-14M | · | · | · | $-11M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-44M | $-62M | $-43M | $-48M | $-48M | $-41M | $-28M | $-17M | $-15M | $-34M | $-18M | $-7M | $-13M | $-35M | $-10M | $-7M | |
| CapEx | $0 | $0 | $20.0K | $26.0K | $36.0K | $851.0K | $449.0K | $-8.0K | $-3.0K | $67.0K | $3.0K | $45.0K | $12.0K | $29.0K | $12.0K | $19.0K | |
| Investing Cash Flow | $22M | $58M | $-223M | $50M | $52M | $-273M | $-1M | $-71M | $-220M | $-67.0K | $-3.0K | $-45.0K | $-12.0K | $-29.0K | $-12.0K | $-19.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | · | |
| Financing Cash Flow | $32M | $2M | $217M | $12M | $892.0K | $244M | $29M | $426.0K | $173M | $16M | $8M | $460.0K | $154M | $77M | $149M | $3M | |
| Net Change in Cash | $10M | $-2M | $-50M | $13M | $5M | $-70M | $-202.0K | $-88M | $-62M | $-18M | $-10M | $-7M | $141M | $42M | $139M | $-4M | |
| Taxes Paid | · | · | · | · | · | · | $263.0K | $4.0K | $33.0K | $0 | $22.0K | $78.0K | $0 | $0 | $0 | · | |
| Free Cash Flow | · | $-62M | · | · | · | $-42M | · | · | · | $-34M | · | · | · | $-35M | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.5% | -8.7% | · | -11.1% | -9.4% | -6.4% | · | -6.1% | -5.9% | -9.0% | · | -5.9% | -6.4% | -12.4% | · | -2.5% | |
| ROE | -9.5% | -9.4% | · | -12.0% | -10.0% | -6.8% | · | -6.4% | -6.1% | -9.4% | · | -6.1% | -6.7% | -13.2% | · | -2.7% | |
| ROIC | -10.1% | -10.1% | · | -11.8% | -10.0% | -6.1% | · | -7.0% | -6.3% | -9.3% | · | -5.3% | -4.7% | -10.8% | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.1 | 24.0 | · | 23.5 | 32.1 | 37.7 | · | 19.4 | 25.0 | 23.7 | · | 26.0 | 39.4 | 24.3 | · | 71.5 | |
| Quick Ratio | 23.6 | 23.4 | · | 23.0 | 31.5 | 37.1 | · | 19.1 | 24.7 | 23.1 | · | 25.7 | 39.0 | 23.7 | · | 69.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -91.1 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-241M | $-215M | · | $-178M | $-142M | $-114M | · | $-94M | $-83M | $-80M | · | $-69M | $-64M | $-58M | · | $-54M | |
| Market Cap | $2.80B | $2.44B | · | $2.31B | $1.84B | $1.72B | · | $1.46B | $1.34B | $1.54B | · | $1.13B | $1.01B | $415M | · | $2.13B | |
| P/E | -11.2 | -10.6 | · | -12.6 | -11.7 | -12.3 | · | -13.7 | -13.1 | -17.2 | · | -2.4 | -1.5 | -0.5 | · | -1.3 | |
| P/B | 4.4 | 3.5 | · | 4.0 | 3.0 | 2.6 | · | 3.1 | 2.7 | 4.5 | · | 3.2 | 2.7 | 1.8 | · | 20.4 | |
| P / Tangible Book | 4.4 | 3.5 | · | 4.0 | 3.0 | 2.6 | · | 3.1 | 2.7 | 4.5 | · | 3.2 | 2.7 | 1.8 | · | 20.4 | |
| P / Cash Flow | · | -39.2 | · | · | · | -41.5 | · | · | · | -45.8 | · | · | · | -11.7 | · | · | |
| P / FCF | · | -39.2 | · | · | · | -40.7 | · | · | · | -45.7 | · | · | · | -11.7 | · | · | |
| Earnings Yield | -8.9% | -9.4% | · | -8.0% | -8.5% | -8.1% | · | -7.3% | -7.6% | -5.8% | · | -41.2% | -65.1% | -183.2% | · | -77.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-212M | $-109M | $-76M | $-47M | $-36M |
| Verwässerte EPS | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-40.95 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 21.9 | 21.2 | 17.1 | 8.8 | 9.4 |
| Quick Ratio | 21.6 | 21.0 | 16.8 | 8.6 | 9.2 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-181M | $-94M | $-74M | $-42M | $-60M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 239 Einreicher · $2.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 52 (+3 vs. Vorquartal) | 21 (-16 vs. Vorquartal) | 73 (-9 vs. Vorquartal) | 64 (+24 vs. Vorquartal) | +3.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $206.953.287 | 2.829.550 | 8,25% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $179.209.164 | 2.450.221 | 7,14% | Aktien |
| VANGUARD GROUP INC | $120.966.365 | 1.523.314 | 4,82% | Aktien |
| STATE STREET CORP | $120.595.865 | 1.648.836 | 4,81% | Aktien |
| Vestal Point Capital, LP | $113.367.000 | 1.550.000 | 4,52% | Aktien |
| Atlas Venture Life Science Advisors, LLC | $110.724.818 | 1.513.875 | 4,41% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $100.130.635 | 1.369.027 | 3,99% | Aktien |
| Frazier Life Sciences Management, L.P. | $99.093.875 | 1.354.852 | 3,95% | Aktien |
| TCG Crossover Management, LLC | $98.143.787 | 1.341.862 | 3,91% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $90.922.967 | 1.243.136 | 3,62% | Aktien |
| BVF INC/IL | $84.375.182 | 1.153.612 | 3,36% | Aktien |
| Woodline Partners LP | $70.088.672 | 958.281 | 2,79% | Aktien |
| Siren, L.L.C. | $64.977.649 | 888.401 | 2,59% | Aktien |
| Logos Global Management LP | $63.997.500 | 875.000 | 2,55% | Aktien |
| Opaleye Management Inc. | $62.534.700 | 855.000 | 2,49% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $49.411.270 | 675.408 | 1,97% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $48.052.980 | 657.000 | 1,92% | Aktien |
| Bellevue Group AG | $40.958.400 | 560.000 | 1,63% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $39.242.462 | 536.539 | 1,56% | Aktien |
| Saturn V Capital Management LP | $38.378.752 | 524.730 | 1,53% | Aktien |
| ARMISTICE CAPITAL, LLC | $33.644.400 | 460.000 | 1,34% | Aktien |
| JENNISON ASSOCIATES LLC | $32.146.492 | 439.520 | 1,28% | Aktien |
| Aberdeen Group plc | $32.048.046 | 438.174 | 1,28% | Aktien |
| Palo Alto Investors LP | $30.473.488 | 416.646 | 1,21% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $28.938.480 | 395.651 | 1,15% | Aktien |
| Pictet Asset Management Holding SA | $28.186.328 | 385.375 | 1,12% | Aktien |
| Assenagon Asset Management S.A. | $28.097.316 | 384.158 | 1,12% | Aktien |
| Foresite Capital Management V, LLC | $27.359.407 | 374.069 | 1,09% | Aktien |
| ORBIMED ADVISORS LLC | $26.150.110 | 357.535 | 1,04% | Aktien |
| BAKER BROS. ADVISORS LP | $25.573.913 | 349.657 | 1,02% | Aktien |
| LOOMIS SAYLES & CO L P | $23.226.924 | 317.568 | 0,93% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.620.872 | 281.937 | 0,82% | Aktien |
| Octagon Capital Advisors LP | $19.747.800 | 270.000 | 0,79% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.824.919 | 257.382 | 0,75% | Aktien |
| Checkpoint Capital L.P. | $17.562.743 | 240.125 | 0,70% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $16.470.982 | 225.198 | 0,66% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $13.508.592 | 184.695 | 0,54% | Aktien |
| Catalio Capital Management, LP | $11.657.346 | 159.384 | 0,46% | Aktien |
| Caption Management, LLC | $10.971.000 | 150.000 | 0,44% | Kaufoption |
| Sofinnova Investments, Inc. | $10.695.920 | 146.239 | 0,43% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $10.329.855 | 141.234 | 0,41% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $10.001.895 | 136.750 | 0,40% | Aktien |
| Alyeska Investment Group, L.P. | $9.142.500 | 125.000 | 0,36% | Aktien |
| Ensign Peak Advisors, Inc | $8.931.199 | 122.111 | 0,36% | Aktien |
| Trexquant Investment LP | $7.877.105 | 107.699 | 0,31% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $7.809.085 | 106.769 | 0,31% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.770.979 | 106.248 | 0,31% | Aktien |
| BANK OF AMERICA CORP /DE/ | $6.884.814 | 94.132 | 0,27% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6.055.992 | 82.800 | 0,24% | Aktien |
| Squarepoint Ops LLC | $5.549.278 | 75.872 | 0,22% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.383.104 | 73.600 | 0,21% | Kaufoption |
| DNB Asset Management AS | $5.348.509 | 73.127 | 0,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.960.721 | 67.825 | 0,20% | Aktien |
| Casdin Capital, LLC | $4.754.100 | 65.000 | 0,19% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $4.647.169 | 63.538 | 0,19% | Aktien |
| Bank of New York Mellon Corp | $4.572.786 | 62.521 | 0,18% | Aktien |
| PEAK6 LLC | $4.388.400 | 60.000 | 0,17% | Kaufoption |
| KVP Capital Advisors, LP | $4.260.405 | 58.250 | 0,17% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $4.227.199 | 57.796 | 0,17% | Aktien |
| XTX Topco Ltd | $4.147.769 | 56.710 | 0,17% | Aktien |
| NEXTBio Capital Management LP | $3.851.187 | 52.655 | 0,15% | Aktien |
| ALGERT GLOBAL LLC | $3.792.309 | 51.850 | 0,15% | Aktien |
| ExodusPoint Capital Management, LP | $3.775.706 | 51.623 | 0,15% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3.700.713 | 49.674 | 0,15% | Aktien |
| Burkehill Global Management, LP | $3.657.000 | 50.000 | 0,15% | Aktien |
| Swiss National Bank | $3.642.372 | 49.800 | 0,15% | Aktien |
| AMERIPRISE FINANCIAL INC | $3.355.224 | 45.874 | 0,13% | Aktien |
| Atle Fund Management AB | $3.194.901 | 43.682 | 0,13% | Aktien |
| Quadrature Capital Ltd | $3.102.526 | 42.419 | 0,12% | Aktien |
| Brevan Howard Capital Management LP | $3.063.542 | 41.886 | 0,12% | Aktien |
| ALPS ADVISORS INC | $2.820.644 | 38.565 | 0,11% | Aktien |
| CITIGROUP INC | $2.683.068 | 36.684 | 0,11% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2.679.411 | 36.634 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $2.621.620 | 35.844 | 0,10% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $2.562.387 | 35.034 | 0,10% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $2.559.900 | 35.000 | 0,10% | Aktien |
| MARSHALL WACE, LLP | $2.515.577 | 34.394 | 0,10% | Aktien |
| BANK OF MONTREAL /CAN/ | $2.359.350 | 32.258 | 0,09% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.216.800 | 34.670 | 0,09% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.198.385 | 34.382 | 0,09% | Aktien |
| RTW INVESTMENTS, LP | $2.194.200 | 30.000 | 0,09% | Aktien |
| Squadron Capital Management LLC | $2.194.200 | 30.000 | 0,09% | Kaufoption |
| VICTORY CAPITAL MANAGEMENT INC | $2.129.618 | 29.117 | 0,08% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $2.096.412 | 28.663 | 0,08% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.031.171 | 27.771 | 0,08% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $1.966.588 | 26.888 | 0,08% | Aktien |
| Rafferty Asset Management, LLC | $1.943.037 | 26.566 | 0,08% | Aktien |
| Campbell & CO Investment Adviser LLC | $1.870.044 | 25.568 | 0,07% | Aktien |
| BlackRock, Inc. | $1.617.491 | 22.115 | 0,06% | Aktien |
| TD Asset Management Inc | $1.579.824 | 21.600 | 0,06% | Aktien |
| Engineers Gate Manager LP | $1.430.033 | 19.552 | 0,06% | Aktien |
| DLD Asset Management, LP | $1.330.238 | 18.200 | 0,05% | Verkaufsoption |
| CITADEL ADVISORS LLC | $1.258.008 | 17.200 | 0,05% | Verkaufsoption |
| MetLife Investment Management, LLC | $1.213.246 | 16.588 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $1.199.203 | 16.396 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.178.359 | 16.111 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $1.155.612 | 15.800 | 0,05% | Kaufoption |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.128.477 | 15.429 | 0,04% | Aktien |
| Man Group plc | $1.091.615 | 14.925 | 0,04% | Aktien |
| HighVista Strategies LLC | $1.039.978 | 14.219 | 0,04% | Aktien |
Unternehmensinsider 30 Insider · 12 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John D Quisel | Chief Executive Officer | 17. August 2026 M | 226.064 | 0 | 14 | $-12.028.932 |
| Jason Patrick Meyenburg | Chief Executive Officer | 3. Januar 2022 A | 13.000 | 0 | 0 | $0 |
| Jean M. Franchi | Chief Financial Officer | 14. April 2026 S | 64.333 | 0 | 6 | $-1.204.945 |
| Joanne Bryce | Chief Financial Officer | 10. Januar 2024 A | 23.665 | 0 | 0 | $0 |
| Brian Piekos | CFO | 31. Mai 2022 A | 17.615 | 0 | 0 | $0 |
| William Jacob Savage | Chief Medical Officer | 13. April 2026 S | 79.480 | 0 | 8 | $-2.265.589 |
| Pamela Stephenson | Chief Commercial Officer | 17. Februar 2026 S | 80.998 | 0 | 1 | $-347.679 |
| Brian Richard Macdonald | Chief Innovation Officer | 30. Juni 2023 S | 12.276 | 0 | 0 | $0 |
| Walter Strapps | Chief Scientific Officer | 29. April 2021 A | — | 0 | 0 | $0 |
| Samuel B. Barone | Chief Medical Officer | 12. April 2021 A | — | 0 | 0 | $0 |
| Marc Uknis | Chief Medical Officer | 5. Februar 2021 A | — | 0 | 0 | $0 |
| Scott Lauder | Chief Technology Officer | 5. Februar 2021 A | — | 0 | 0 | $0 |
| Donald William Nicholson | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| William Richard White | Direktor | 18. Juni 2026 A | 0 | 0 | 0 | $0 |
| Mark Chin | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Nadim Ahmed | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Kevin Bitterman | Direktor | 18. Juni 2026 A | 14.161 | 0 | 19 | $-16.858.638 |
| Liam Ratcliffe | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Georges Gemayel | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Mona Ashiya | Direktor | 11. Juni 2025 A | 186.541 | 0 | 0 | $0 |
| Jay T. Backstrom | Direktor | 29. Dezember 2022 A | — | 0 | 0 | $0 |
| Tuyen Ong | Direktor | 4. Oktober 2021 A | — | 0 | 0 | $0 |
| James B. Tananbaum | Direktor | 4. Oktober 2021 A | — | 0 | 0 | $0 |
| Jason P Rhodes | Direktor | 4. Oktober 2021 A | — | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 4. Oktober 2021 A | — | 0 | 0 | $0 |
| David Charles Lubner | Direktor | 12. März 2021 A | — | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 28. Juni 2023 S | 1.090.772 | 0 | 0 | $0 |
| Jonathan Yen-Wen Yu | — | 12. August 2026 M | 54.324 | 0 | 11 | $-4.833.128 |
| Rahul Khara | — | 6. August 2026 M | 52.324 | 0 | 11 | $-1.874.683 |
| Precillia Redmond | — | 5. Februar 2021 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 6 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LP, Atlas Venture Associates Opportunity II, LLC ×6 Einreichungen | 17. Dezember 2025 | 2,20% | Änderung | — | SEC |
| AI DMI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×7 Einreichungen | 22. Oktober 2025 | 8,00% | Änderung | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC ×6 Einreichungen | 12. März 2025 | 4,50% | Änderung | — | SEC |
| Adage Capital Partners, L.P., Adage Capital Partners GP, L.L.C., Adage Capital Advisors, L.L.C., Robert Atchinson, Phillip Gross ×3 Einreichungen | 16. Februar 2023 | — | Erste Einreichung | — | SEC |
| Lightstone Ventures, L.P., Lightstone Ventures (A), L.P., LSV Associates, LLC, Lightstone Singapore, L.P., Lightstone Singapore Associates, LLC, Michael A. Carusi, Jean M. George, Henry A. Plain, Jr. ×2 Einreichungen | 14. Februar 2023 | — | Erste Einreichung | — | SEC |
| FS Development Holdings, LLC, Foresite Capital Fund V, L.P., Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC, James Tananbaum ×3 Einreichungen | 5. Januar 2023 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 46 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 1,69% | 39.334 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,18% | 6.926 NS | 31. Mai 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 0,86% | 27.470 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,74% | 57.978 NS | 30. April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,53% | 3.004 NS | 30. April 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 636 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 2.080 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,16% | 202.771 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,13% | 254.812 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,13% | 1.411 NS | 31. Mai 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 30.333 SH | 8. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,10% | 19.972 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,09% | 356 NS | 30. April 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 10.028 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,09% | 11.028 SH | 8. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,08% | 986 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 724.632 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 162.749 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 20.807 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,06% | 11.910 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,05% | 112.189 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,05% | 1.293 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 152.195 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 1.550 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 11.895 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 366.845 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 74.680 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,03% | 1.011 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 11.162 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 8.781 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 1.824 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 1.021 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.076 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 60.244 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 915 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 26 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 11.918 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 7.752 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 12.978 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 49.447 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 8.370 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18.441 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 318 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 971.123 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.280 SH | 8. August 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | -0,03% | -10.643 NS | 30. April 2026 | N-PORT |